March 2017 Deal Watch Review available.
Bridget started out her career as a Chartered Accountant and specialised in business valuations at Ernst & Young before moving into Healthcare. Bridget has more than 15 years of experience in the Healthcare industry across Pharmaceuticals, Vaccines and Life Sciences in the UK and Asia for GSK, Chiron Vaccines (later Novartis Vaccines and Diagnostics), GE Healthcare and as an independent business development consultant.
At GSK Bridget held a series of corporate finance and business development roles in the UK, Singapore and Japan. She subsequently led the Alliance Management activities at Chiron Vaccines (later Novartis Vaccines and Diagnostics). More recently Bridget worked in Business Development at GE Healthcare where she led due diligence and deal execution on acquisitions and divestitures of Life Science businesses.
Bridget joined Medius at the end of 2009 and brings her international healthcare experience together with excellent analytical and communications skills to provide strong commercial rigour to drive and support strategic portfolio and investment decisions.
Bridget holds a BSc in Psychology and is a member of ICEAW and the Pharmaceutical Licensing Group. She is also an author of the Medius monthly Deal Watch articles published in the PME.